Ignite Creation Date:
2025-12-25 @ 1:07 AM
Ignite Modification Date:
2026-01-03 @ 2:50 AM
Study NCT ID:
NCT00622193
Status:
COMPLETED
Last Update Posted:
2017-04-14
First Post:
2008-02-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer
Sponsor:
Helsinn Therapeutics (U.S.), Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-03
Start Date Type:
None
Primary Completion Date:
2009-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-12
Completion Date Type:
ACTUAL
First Submit Date:
2008-02-12
First Submit QC Date:
None
Study First Post Date:
2008-02-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2011-06-23
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-04-12
Last Update Post Date:
2017-04-14
Last Update Post Date Type:
ACTUAL